Spotlight on Humacyte: Analyzing the Surge in Options Activity
Spotlight on Humacyte: Analyzing the Surge in Options Activity
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humacyte's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Humacyte's significant trades, within a strike price range of $4.0 to $7.5, over the past month.Financial giants have made a conspicuous bearish move on Humacyte. Our analysis of options history for Humacyte (NASDAQ:HUMA) revealed 9 unusual trades.
金融巨頭對Humacyte做出了顯著的看淡操作。我們對Humacyte（納斯達克:HUMA）期權歷史的分析揭示了9筆期權異動交易。
Delving into the details, we found 11% of traders were bullish, while 77% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $370,504, and 4 were calls, valued at $132,840.
深入細節，我們發現11%的交易者看好，而77%則表現出看淡的傾向。在我們發現的所有交易中，有5筆是看跌期權，價值370,504美元，4筆是看漲期權，價值132,840美元。
Expected Price Movements
預期價格變動
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $4.0 to $7.5 for Humacyte over the recent three months.
根據交易活動，看來重大投資者在過去三個月內將目標價格區間定在4.0美元到7.5美元之間。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humacyte's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Humacyte's significant trades, within a strike price range of $4.0 to $7.5, over the past month.
檢查成交量和未平倉合約的信息提供了關於股票研究的重要洞見。這些信息對於評估Humacyte在特定行權價的流動性和興趣水平至關重要。下面，我們展示了Humacyte在過去一個月內在4.0美元到7.5美元的行權價範圍內看漲和看跌期權的成交量和未平倉合約的趨勢快照。
Humacyte Call and Put Volume: 30-Day Overview
Humacyte看漲和看跌期權成交量：30天概覽
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMA | PUT | SWEEP | BEARISH | 01/17/25 | $1.35 | $1.3 | $1.35 | $5.50 | $114.5K | 21 | 384 |
| HUMA | PUT | SWEEP | BEARISH | 03/21/25 | $1.45 | $1.4 | $1.45 | $5.00 | $100.0K | 4.4K | 63 |
| HUMA | PUT | SWEEP | BEARISH | 02/21/25 | $1.45 | $1.25 | $1.45 | $5.00 | $64.8K | 10 | 512 |
| HUMA | PUT | SWEEP | BULLISH | 01/17/25 | $0.7 | $0.65 | $0.65 | $4.50 | $57.9K | 141 | 908 |
| HUMA | CALL | TRADE | BEARISH | 12/20/24 | $2.25 | $2.0 | $2.0 | $4.00 | $40.0K | 1.0K | 208 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 行權價 | 總交易價格 | 未平倉合約 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMA | 看跌 | 掃單 | 看淡 | 01/17/25 | $1.35 | $1.3 | $1.35 | $5.50 | $114.5K | 21 | 384 |
| HUMA | 看跌 | 掃單 | 看淡 | 03/21/25 | $1.45 | $1.4 | $1.45 | $5.00 | 100,000美元 | 4.4K | 63 |
| HUMA | 看跌 | 掃單 | 看淡 | 02/21/25 | $1.45 | $1.25 | $1.45 | $5.00 | 64.8K美元 | 10 | 512 |
| HUMA | 看跌 | 掃單 | 看好 | 01/17/25 | $0.7 | $0.65 | $0.65 | $4.50 | $57.9K | 141 | 908 |
| HUMA | 看漲 | 交易 | 看淡 | 12/20/24 | $2.25 | $2.0 | $2.0 | $4.00 | $40.0K | 1.0K | 208 |
About Humacyte
關於Humacyte
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Humacyte公司正在開發一種顛覆性的生物技術平台，以提供普遍可植入的生物工程人類組織和器官，旨在改善患者生活質量並改進醫學實踐。它開發並生產無細胞組織，以治療各種疾病、傷害和慢性病。
After a thorough review of the options trading surrounding Humacyte, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在對Humacyte相關的期權交易進行徹底審查後，我們將進一步詳細研究該公司。這包括對其當前市場狀態和表現的評估。
Where Is Humacyte Standing Right Now?
Humacyte目前的狀況如何？
- With a trading volume of 42,801,618, the price of HUMA is up by 66.66%, reaching $5.77.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 91 days from now.
- 截至目前，HUMA的交易量爲42,801,618，價格上漲了66.66%，達到5.77美元。
- 當前的RSI值表明該股票可能已接近超買。
- 下一個業績預計將在91天后發佈。
What Analysts Are Saying About Humacyte
分析師對Humacyte的看法
3 market experts have recently issued ratings for this stock, with a consensus target price of $21.666666666666668.
最近有3位市場專家對該股票發佈了評級，市場共識目標價爲21.67美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：聰明資金正在行動
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Consistent in their evaluation, an analyst from D. Boral Capital keeps a Buy rating on Humacyte with a target price of $25. * An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $15. * An analyst from D. Boral Capital persists with their Buy rating on Humacyte, maintaining a target price of $25.
Benzinga Edge的期權異動板塊在事件發生前能夠發現潛在的市場動向。查看大資金在您喜愛的股票上的持倉。點擊這裏獲取訪問權限。* 在評估中保持一致，D. Boral Capital的分析師對Humacyte保持買入評級，目標價爲25美元。* HC Wainwright & Co.的一位分析師將其評級下調至買入，並調整目標價格至15美元。* D. Boral Capital的分析師繼續維護對Humacyte的買入評級，保持目標價爲25美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humacyte with Benzinga Pro for real-time alerts.
交易期權涉及更高的風險，但也提供了更高利潤的潛力。聰明的交易者通過持續的教育、戰略性交易調整、利用各種因數以及隨時關注市場動態來降低這些風險。通過Benzinga Pro跟蹤Humacyte的最新期權交易，以獲取實時警報。
譯文內容由第三人軟體翻譯。
